These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. A Retrospective Analysis of R-MPV Plus Response-adapted Whole-brain Radiotherapy for Elderly Patients with Primary Central Nervous System Lymphoma. Suzuki Y; Imoto N; Ishihara S; Fujiwara S; Ito R; Sakai T; Yamamoto S; Sugiura I; Kurahashi S Intern Med; 2022 May; 61(9):1345-1352. PubMed ID: 34670884 [TBL] [Abstract][Full Text] [Related]
5. Primary CNS lymphoma in patients younger than 60: can whole-brain radiotherapy be deferred? Omuro A; Taillandier L; Chinot O; Sierra Del Rio M; Carnin C; Barrie M; Soussain C; Tanguy ML; Choquet S; Leblond V; Hoang-Xuan K; J Neurooncol; 2011 Aug; 104(1):323-30. PubMed ID: 21170569 [TBL] [Abstract][Full Text] [Related]
6. Whole brain radiotherapy improves survival outcomes in primary CNS lymphoma patients ineligible for systemic therapy. Song J; Samant R; Jay M; Chaudry H; Fan XY; MacDonald D; Bence-Bruckler I; Nair V Support Care Cancer; 2020 Nov; 28(11):5363-5369. PubMed ID: 32140974 [TBL] [Abstract][Full Text] [Related]
7. Early whole brain radiotherapy in primary CNS lymphoma: negative impact on quality of life in the randomized G-PCNSL-SG1 trial. Herrlinger U; Schäfer N; Fimmers R; Griesinger F; Rauch M; Kirchen H; Roth P; Glas M; Bamberg M; Martus P; Thiel E; Korfel A; Weller M J Cancer Res Clin Oncol; 2017 Sep; 143(9):1815-1821. PubMed ID: 28434043 [TBL] [Abstract][Full Text] [Related]
8. Consolidative or palliative whole brain radiation for secondary CNS diffuse large B-Cell lymphoma. Walburn T; Grover NS; Shen CJ; Ranganathan R; Dittus C; Beaven AW; Wang AZ; Wang K Leuk Lymphoma; 2021 Jan; 62(1):68-75. PubMed ID: 32935601 [TBL] [Abstract][Full Text] [Related]
9. [Therapeutic management of central nervous system lymphomas in a single hematological institute]. Iványi JL; Marton E; Plander M; Gyánó G; Czumbil L; Tóth C Orv Hetil; 2009 Oct; 150(42):1937-44. PubMed ID: 19812012 [TBL] [Abstract][Full Text] [Related]
10. Role of radiation therapy in primary central nervous system lymphoma : KROG 14-20 Collaborative Study of Brain and Lymphoma Committee. Koh HK; Kim IH; Kim TM; Lim DH; Oh D; Cho JH; Kim WC; Kim JH; Chung WK; Jeong BK; Kang KM; Hong S; Suh CO; Kim IA J Neurooncol; 2017 Dec; 135(3):629-638. PubMed ID: 28939931 [TBL] [Abstract][Full Text] [Related]
11. Balancing relapses versus cognitive impairment in primary central nervous system lymphoma: a single-center experience. Chanswangphuwana C; Rojnuckarin P; Cherdchoo N; Raiyawa T; Uaprasert N Hematology; 2018 Aug; 23(7):385-390. PubMed ID: 29256330 [TBL] [Abstract][Full Text] [Related]
12. Radiotherapy in the treatment of primary central nervous system lymphoma (PCNSL). Nelson DF J Neurooncol; 1999 Jul; 43(3):241-7. PubMed ID: 10563430 [TBL] [Abstract][Full Text] [Related]
13. High-dose methotrexate with or without whole brain radiotherapy for primary CNS lymphoma (G-PCNSL-SG-1): a phase 3, randomised, non-inferiority trial. Thiel E; Korfel A; Martus P; Kanz L; Griesinger F; Rauch M; Röth A; Hertenstein B; von Toll T; Hundsberger T; Mergenthaler HG; Leithäuser M; Birnbaum T; Fischer L; Jahnke K; Herrlinger U; Plasswilm L; Nägele T; Pietsch T; Bamberg M; Weller M Lancet Oncol; 2010 Nov; 11(11):1036-47. PubMed ID: 20970380 [TBL] [Abstract][Full Text] [Related]
14. Whole brain radiotherapy plus simultaneous in-field boost with image guided intensity-modulated radiotherapy for brain metastases of non-small cell lung cancer. Zhou L; Liu J; Xue J; Xu Y; Gong Y; Deng L; Wang S; Zhong R; Ding Z; Lu Y Radiat Oncol; 2014 May; 9():117. PubMed ID: 24884773 [TBL] [Abstract][Full Text] [Related]
15. Results of whole-brain radiation as salvage of methotrexate failure for immunocompetent patients with primary CNS lymphoma. Nguyen PL; Chakravarti A; Finkelstein DM; Hochberg FH; Batchelor TT; Loeffler JS J Clin Oncol; 2005 Mar; 23(7):1507-13. PubMed ID: 15735126 [TBL] [Abstract][Full Text] [Related]
16. [A single-center, retrospective analysis of relapse and progression patterns of primary central nervous system lymphoma: can whole brain radiotherapy be replaced?]. Qin Y; Liu R; Zhang X; Zhang W; Ren C; Wu D Nan Fang Yi Ke Da Xue Xue Bao; 2023 Apr; 43(4):499-506. PubMed ID: 37202184 [TBL] [Abstract][Full Text] [Related]
17. Stereotactic Radiosurgery for Primary Central Nervous System Lymphoma. Wu SY; Braunstein SE; Rubenstein JL; Sneed PK Cureus; 2023 Feb; 15(2):e34817. PubMed ID: 36915845 [TBL] [Abstract][Full Text] [Related]
18. Long-term outcomes with reduced-dose whole-brain radiotherapy and a stereotactic radiosurgery boost for primary central nervous system lymphoma. Foreman BE; Mullikin TC; Floyd SR; Kelsey CR; Patel MP; Peters KB; Kirkpatrick JP; Reitman ZJ; Vaios EJ Neurooncol Adv; 2023; 5(1):vdad097. PubMed ID: 37706200 [TBL] [Abstract][Full Text] [Related]
19. Late radiation toxicity after whole brain radiotherapy: the influence of antiepileptic drugs. Nieder C; Leicht A; Motaref B; Nestle U; Niewald M; Schnabel K Am J Clin Oncol; 1999 Dec; 22(6):573-9. PubMed ID: 10597741 [TBL] [Abstract][Full Text] [Related]
20. Partial-brain radiotherapy for primary central nervous system lymphoma: multi-institutional experience. Iwabuchi M; Shibamoto Y; Sugie C; Ayakawa S; Ogino H; Baba F J Radiat Res; 2016 Mar; 57(2):164-8. PubMed ID: 26661856 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]